Medicare Expands Coverage For Spinal Cord Stimulation To Treat Diabetic Peripheral Neuropathy
Nevro Executives Say Their Device Offers An Option For Patients With Pain
Medicare’s recent expansion of coverage for spinal cord stimulation therapy to treat diabetic peripheral neuropathy could mean relief for some 11 million Americans. Executives from Redwood City, CA device maker Nevro talked to Medtech Insight about the expansion and what it means for patients who use their technology.
